Genetic Diversity of Meningococcal Serogroup B Vaccine Antigens among Carriage Isolates Collected from Students at Three Universities in the United States, 2015–2016
The impact of serogroup B meningococcal (MenB) vaccines on carriage is not completely understood. Using whole-genome sequencing data, we assessed the diversity and distribution of MenB vaccine antigens (particularly FHbp) among 1,514 meningococcal carriage isolates recovered from vaccinated and unva...
Saved in:
| Published in | mBio Vol. 12; no. 3 |
|---|---|
| Main Authors | , , , , , , , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
United States
American Society for Microbiology
18.05.2021
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | The impact of serogroup B meningococcal (MenB) vaccines on carriage is not completely understood. Using whole-genome sequencing data, we assessed the diversity and distribution of MenB vaccine antigens (particularly FHbp) among 1,514 meningococcal carriage isolates recovered from vaccinated and unvaccinated students at three U.S. universities, two of which underwent MenB-FHbp mass vaccination campaigns following meningococcal disease outbreaks.
Carriage evaluations were conducted during 2015 to 2016 at two U.S. universities in conjunction with the response to disease outbreaks caused by
Neisseria meningitidis
serogroup B and at a university where outbreak and response activities had not occurred. All eligible students at the two universities received the serogroup B meningococcal factor H binding protein vaccine (MenB-FHbp); 5.2% of students (181/3,509) at one university received MenB-4C. A total of 1,514 meningococcal carriage isolates were obtained from 8,905 oropharyngeal swabs from 7,001 unique participants. Whole-genome sequencing data were analyzed to understand MenB-FHbp’s impact on carriage and antigen genetic diversity and distribution. Of 1,422 isolates from carriers with known vaccination status (726 [51.0%] from MenB-FHbp-vaccinated, 42 [3.0%] from MenB-4C-vaccinated, and 654 [46.0%] from unvaccinated participants), 1,406 (98.9%) had intact
fHbp
alleles (716 from MenB-FHbp-vaccinated participants). Of 726 isolates from MenB-FHbp-vaccinated participants, 250 (34.4%) harbored FHbp peptides that may be covered by MenB-FHbp. Genogroup B was detected in 122/1,422 (8.6%) and 112/1,422 (7.9%) isolates from MenB-FHbp-vaccinated and unvaccinated participants, respectively. FHbp subfamily and peptide distributions between MenB-FHbp-vaccinated and unvaccinated participants were not statistically different. Eighteen of 161 MenB-FHbp-vaccinated repeat carriers (11.2%) acquired a new strain containing one or more new vaccine antigen peptides during multiple rounds of sample collection, which was not statistically different (
P
= 0.3176) from the unvaccinated repeat carriers (1/30; 3.3%). Our findings suggest that lack of MenB vaccine impact on carriage was not due to missing the intact
fHbp
gene; MenB-FHbp did not affect antigen genetic diversity and distribution during the study period.
IMPORTANCE
The impact of serogroup B meningococcal (MenB) vaccines on carriage is not completely understood. Using whole-genome sequencing data, we assessed the diversity and distribution of MenB vaccine antigens (particularly FHbp) among 1,514 meningococcal carriage isolates recovered from vaccinated and unvaccinated students at three U.S. universities, two of which underwent MenB-FHbp mass vaccination campaigns following meningococcal disease outbreaks. The majority of carriage isolates recovered from participants harbored intact
fHbp
genes, about half of which were recovered from MenB-FHbp-vaccinated participants. The distribution of vaccine antigen peptides was similar among carriage isolates recovered from vaccinated and unvaccinated participants, and almost all strains recovered from repeat carriers retained the same vaccine antigen profile, suggesting insignificant vaccine selective pressure on the carriage population in these universities. |
|---|---|
| AbstractList | Carriage evaluations were conducted during 2015 to 2016 at two U.S. universities in conjunction with the response to disease outbreaks caused by Neisseria meningitidis serogroup B and at a university where outbreak and response activities had not occurred. All eligible students at the two universities received the serogroup B meningococcal factor H binding protein vaccine (MenB-FHbp); 5.2% of students (181/3,509) at one university received MenB-4C. A total of 1,514 meningococcal carriage isolates were obtained from 8,905 oropharyngeal swabs from 7,001 unique participants. Whole-genome sequencing data were analyzed to understand MenB-FHbp’s impact on carriage and antigen genetic diversity and distribution. Of 1,422 isolates from carriers with known vaccination status (726 [51.0%] from MenB-FHbp-vaccinated, 42 [3.0%] from MenB-4C-vaccinated, and 654 [46.0%] from unvaccinated participants), 1,406 (98.9%) had intact fHbp alleles (716 from MenB-FHbp-vaccinated participants). Of 726 isolates from MenB-FHbp-vaccinated participants, 250 (34.4%) harbored FHbp peptides that may be covered by MenB-FHbp. Genogroup B was detected in 122/1,422 (8.6%) and 112/1,422 (7.9%) isolates from MenB-FHbp-vaccinated and unvaccinated participants, respectively. FHbp subfamily and peptide distributions between MenB-FHbp-vaccinated and unvaccinated participants were not statistically different. Eighteen of 161 MenB-FHbp-vaccinated repeat carriers (11.2%) acquired a new strain containing one or more new vaccine antigen peptides during multiple rounds of sample collection, which was not statistically different (P = 0.3176) from the unvaccinated repeat carriers (1/30; 3.3%). Our findings suggest that lack of MenB vaccine impact on carriage was not due to missing the intact fHbp gene; MenB-FHbp did not affect antigen genetic diversity and distribution during the study period. IMPORTANCE The impact of serogroup B meningococcal (MenB) vaccines on carriage is not completely understood. Using whole-genome sequencing data, we assessed the diversity and distribution of MenB vaccine antigens (particularly FHbp) among 1,514 meningococcal carriage isolates recovered from vaccinated and unvaccinated students at three U.S. universities, two of which underwent MenB-FHbp mass vaccination campaigns following meningococcal disease outbreaks. The majority of carriage isolates recovered from participants harbored intact fHbp genes, about half of which were recovered from MenB-FHbp-vaccinated participants. The distribution of vaccine antigen peptides was similar among carriage isolates recovered from vaccinated and unvaccinated participants, and almost all strains recovered from repeat carriers retained the same vaccine antigen profile, suggesting insignificant vaccine selective pressure on the carriage population in these universities. The impact of serogroup B meningococcal (MenB) vaccines on carriage is not completely understood. Using whole-genome sequencing data, we assessed the diversity and distribution of MenB vaccine antigens (particularly FHbp) among 1,514 meningococcal carriage isolates recovered from vaccinated and unvaccinated students at three U.S. universities, two of which underwent MenB-FHbp mass vaccination campaigns following meningococcal disease outbreaks. Carriage evaluations were conducted during 2015 to 2016 at two U.S. universities in conjunction with the response to disease outbreaks caused by serogroup B and at a university where outbreak and response activities had not occurred. All eligible students at the two universities received the serogroup B meningococcal factor H binding protein vaccine (MenB-FHbp); 5.2% of students (181/3,509) at one university received MenB-4C. A total of 1,514 meningococcal carriage isolates were obtained from 8,905 oropharyngeal swabs from 7,001 unique participants. Whole-genome sequencing data were analyzed to understand MenB-FHbp's impact on carriage and antigen genetic diversity and distribution. Of 1,422 isolates from carriers with known vaccination status (726 [51.0%] from MenB-FHbp-vaccinated, 42 [3.0%] from MenB-4C-vaccinated, and 654 [46.0%] from unvaccinated participants), 1,406 (98.9%) had intact alleles (716 from MenB-FHbp-vaccinated participants). Of 726 isolates from MenB-FHbp-vaccinated participants, 250 (34.4%) harbored FHbp peptides that may be covered by MenB-FHbp. Genogroup B was detected in 122/1,422 (8.6%) and 112/1,422 (7.9%) isolates from MenB-FHbp-vaccinated and unvaccinated participants, respectively. FHbp subfamily and peptide distributions between MenB-FHbp-vaccinated and unvaccinated participants were not statistically different. Eighteen of 161 MenB-FHbp-vaccinated repeat carriers (11.2%) acquired a new strain containing one or more new vaccine antigen peptides during multiple rounds of sample collection, which was not statistically different ( = 0.3176) from the unvaccinated repeat carriers (1/30; 3.3%). Our findings suggest that lack of MenB vaccine impact on carriage was not due to missing the intact gene; MenB-FHbp did not affect antigen genetic diversity and distribution during the study period. The impact of serogroup B meningococcal (MenB) vaccines on carriage is not completely understood. Using whole-genome sequencing data, we assessed the diversity and distribution of MenB vaccine antigens (particularly FHbp) among 1,514 meningococcal carriage isolates recovered from vaccinated and unvaccinated students at three U.S. universities, two of which underwent MenB-FHbp mass vaccination campaigns following meningococcal disease outbreaks. The majority of carriage isolates recovered from participants harbored intact genes, about half of which were recovered from MenB-FHbp-vaccinated participants. The distribution of vaccine antigen peptides was similar among carriage isolates recovered from vaccinated and unvaccinated participants, and almost all strains recovered from repeat carriers retained the same vaccine antigen profile, suggesting insignificant vaccine selective pressure on the carriage population in these universities. Carriage evaluations were conducted during 2015 to 2016 at two U.S. universities in conjunction with the response to disease outbreaks caused by Neisseria meningitidis serogroup B and at a university where outbreak and response activities had not occurred. All eligible students at the two universities received the serogroup B meningococcal factor H binding protein vaccine (MenB-FHbp); 5.2% of students (181/3,509) at one university received MenB-4C. A total of 1,514 meningococcal carriage isolates were obtained from 8,905 oropharyngeal swabs from 7,001 unique participants. Whole-genome sequencing data were analyzed to understand MenB-FHbp's impact on carriage and antigen genetic diversity and distribution. Of 1,422 isolates from carriers with known vaccination status (726 [51.0%] from MenB-FHbp-vaccinated, 42 [3.0%] from MenB-4C-vaccinated, and 654 [46.0%] from unvaccinated participants), 1,406 (98.9%) had intact fHbp alleles (716 from MenB-FHbp-vaccinated participants). Of 726 isolates from MenB-FHbp-vaccinated participants, 250 (34.4%) harbored FHbp peptides that may be covered by MenB-FHbp. Genogroup B was detected in 122/1,422 (8.6%) and 112/1,422 (7.9%) isolates from MenB-FHbp-vaccinated and unvaccinated participants, respectively. FHbp subfamily and peptide distributions between MenB-FHbp-vaccinated and unvaccinated participants were not statistically different. Eighteen of 161 MenB-FHbp-vaccinated repeat carriers (11.2%) acquired a new strain containing one or more new vaccine antigen peptides during multiple rounds of sample collection, which was not statistically different (P = 0.3176) from the unvaccinated repeat carriers (1/30; 3.3%). Our findings suggest that lack of MenB vaccine impact on carriage was not due to missing the intact fHbp gene; MenB-FHbp did not affect antigen genetic diversity and distribution during the study period.IMPORTANCE The impact of serogroup B meningococcal (MenB) vaccines on carriage is not completely understood. Using whole-genome sequencing data, we assessed the diversity and distribution of MenB vaccine antigens (particularly FHbp) among 1,514 meningococcal carriage isolates recovered from vaccinated and unvaccinated students at three U.S. universities, two of which underwent MenB-FHbp mass vaccination campaigns following meningococcal disease outbreaks. The majority of carriage isolates recovered from participants harbored intact fHbp genes, about half of which were recovered from MenB-FHbp-vaccinated participants. The distribution of vaccine antigen peptides was similar among carriage isolates recovered from vaccinated and unvaccinated participants, and almost all strains recovered from repeat carriers retained the same vaccine antigen profile, suggesting insignificant vaccine selective pressure on the carriage population in these universities.Carriage evaluations were conducted during 2015 to 2016 at two U.S. universities in conjunction with the response to disease outbreaks caused by Neisseria meningitidis serogroup B and at a university where outbreak and response activities had not occurred. All eligible students at the two universities received the serogroup B meningococcal factor H binding protein vaccine (MenB-FHbp); 5.2% of students (181/3,509) at one university received MenB-4C. A total of 1,514 meningococcal carriage isolates were obtained from 8,905 oropharyngeal swabs from 7,001 unique participants. Whole-genome sequencing data were analyzed to understand MenB-FHbp's impact on carriage and antigen genetic diversity and distribution. Of 1,422 isolates from carriers with known vaccination status (726 [51.0%] from MenB-FHbp-vaccinated, 42 [3.0%] from MenB-4C-vaccinated, and 654 [46.0%] from unvaccinated participants), 1,406 (98.9%) had intact fHbp alleles (716 from MenB-FHbp-vaccinated participants). Of 726 isolates from MenB-FHbp-vaccinated participants, 250 (34.4%) harbored FHbp peptides that may be covered by MenB-FHbp. Genogroup B was detected in 122/1,422 (8.6%) and 112/1,422 (7.9%) isolates from MenB-FHbp-vaccinated and unvaccinated participants, respectively. FHbp subfamily and peptide distributions between MenB-FHbp-vaccinated and unvaccinated participants were not statistically different. Eighteen of 161 MenB-FHbp-vaccinated repeat carriers (11.2%) acquired a new strain containing one or more new vaccine antigen peptides during multiple rounds of sample collection, which was not statistically different (P = 0.3176) from the unvaccinated repeat carriers (1/30; 3.3%). Our findings suggest that lack of MenB vaccine impact on carriage was not due to missing the intact fHbp gene; MenB-FHbp did not affect antigen genetic diversity and distribution during the study period.IMPORTANCE The impact of serogroup B meningococcal (MenB) vaccines on carriage is not completely understood. Using whole-genome sequencing data, we assessed the diversity and distribution of MenB vaccine antigens (particularly FHbp) among 1,514 meningococcal carriage isolates recovered from vaccinated and unvaccinated students at three U.S. universities, two of which underwent MenB-FHbp mass vaccination campaigns following meningococcal disease outbreaks. The majority of carriage isolates recovered from participants harbored intact fHbp genes, about half of which were recovered from MenB-FHbp-vaccinated participants. The distribution of vaccine antigen peptides was similar among carriage isolates recovered from vaccinated and unvaccinated participants, and almost all strains recovered from repeat carriers retained the same vaccine antigen profile, suggesting insignificant vaccine selective pressure on the carriage population in these universities. The impact of serogroup B meningococcal (MenB) vaccines on carriage is not completely understood. Using whole-genome sequencing data, we assessed the diversity and distribution of MenB vaccine antigens (particularly FHbp) among 1,514 meningococcal carriage isolates recovered from vaccinated and unvaccinated students at three U.S. universities, two of which underwent MenB-FHbp mass vaccination campaigns following meningococcal disease outbreaks. Carriage evaluations were conducted during 2015 to 2016 at two U.S. universities in conjunction with the response to disease outbreaks caused by Neisseria meningitidis serogroup B and at a university where outbreak and response activities had not occurred. All eligible students at the two universities received the serogroup B meningococcal factor H binding protein vaccine (MenB-FHbp); 5.2% of students (181/3,509) at one university received MenB-4C. A total of 1,514 meningococcal carriage isolates were obtained from 8,905 oropharyngeal swabs from 7,001 unique participants. Whole-genome sequencing data were analyzed to understand MenB-FHbp’s impact on carriage and antigen genetic diversity and distribution. Of 1,422 isolates from carriers with known vaccination status (726 [51.0%] from MenB-FHbp-vaccinated, 42 [3.0%] from MenB-4C-vaccinated, and 654 [46.0%] from unvaccinated participants), 1,406 (98.9%) had intact fHbp alleles (716 from MenB-FHbp-vaccinated participants). Of 726 isolates from MenB-FHbp-vaccinated participants, 250 (34.4%) harbored FHbp peptides that may be covered by MenB-FHbp. Genogroup B was detected in 122/1,422 (8.6%) and 112/1,422 (7.9%) isolates from MenB-FHbp-vaccinated and unvaccinated participants, respectively. FHbp subfamily and peptide distributions between MenB-FHbp-vaccinated and unvaccinated participants were not statistically different. Eighteen of 161 MenB-FHbp-vaccinated repeat carriers (11.2%) acquired a new strain containing one or more new vaccine antigen peptides during multiple rounds of sample collection, which was not statistically different ( P = 0.3176) from the unvaccinated repeat carriers (1/30; 3.3%). Our findings suggest that lack of MenB vaccine impact on carriage was not due to missing the intact fHbp gene; MenB-FHbp did not affect antigen genetic diversity and distribution during the study period. IMPORTANCE The impact of serogroup B meningococcal (MenB) vaccines on carriage is not completely understood. Using whole-genome sequencing data, we assessed the diversity and distribution of MenB vaccine antigens (particularly FHbp) among 1,514 meningococcal carriage isolates recovered from vaccinated and unvaccinated students at three U.S. universities, two of which underwent MenB-FHbp mass vaccination campaigns following meningococcal disease outbreaks. The majority of carriage isolates recovered from participants harbored intact fHbp genes, about half of which were recovered from MenB-FHbp-vaccinated participants. The distribution of vaccine antigen peptides was similar among carriage isolates recovered from vaccinated and unvaccinated participants, and almost all strains recovered from repeat carriers retained the same vaccine antigen profile, suggesting insignificant vaccine selective pressure on the carriage population in these universities. Carriage evaluations were conducted during 2015 to 2016 at two U.S. universities in conjunction with the response to disease outbreaks caused by Neisseria meningitidis serogroup B and at a university where outbreak and response activities had not occurred. All eligible students at the two universities received the serogroup B meningococcal factor H binding protein vaccine (MenB-FHbp); 5.2% of students (181/3,509) at one university received MenB-4C. A total of 1,514 meningococcal carriage isolates were obtained from 8,905 oropharyngeal swabs from 7,001 unique participants. Whole-genome sequencing data were analyzed to understand MenB-FHbp’s impact on carriage and antigen genetic diversity and distribution. Of 1,422 isolates from carriers with known vaccination status (726 [51.0%] from MenB-FHbp-vaccinated, 42 [3.0%] from MenB-4C-vaccinated, and 654 [46.0%] from unvaccinated participants), 1,406 (98.9%) had intact fHbp alleles (716 from MenB-FHbp-vaccinated participants). Of 726 isolates from MenB-FHbp-vaccinated participants, 250 (34.4%) harbored FHbp peptides that may be covered by MenB-FHbp. Genogroup B was detected in 122/1,422 (8.6%) and 112/1,422 (7.9%) isolates from MenB-FHbp-vaccinated and unvaccinated participants, respectively. FHbp subfamily and peptide distributions between MenB-FHbp-vaccinated and unvaccinated participants were not statistically different. Eighteen of 161 MenB-FHbp-vaccinated repeat carriers (11.2%) acquired a new strain containing one or more new vaccine antigen peptides during multiple rounds of sample collection, which was not statistically different ( P = 0.3176) from the unvaccinated repeat carriers (1/30; 3.3%). Our findings suggest that lack of MenB vaccine impact on carriage was not due to missing the intact fHbp gene; MenB-FHbp did not affect antigen genetic diversity and distribution during the study period. |
| Author | Acosta, Anna M. Mbaeyi, Sarah Marjuki, Henju Retchless, Adam C. Thomas, Jennifer D. Wang, Xin Whaley, Melissa J. Chang, How-Yi Chen, Alexander Jenkins, Laurel T. Hu, Fang McNamara, Lucy A. Topaz, Nadav Vuong, Jeni Soeters, Heidi M. Schmink, Susanna |
| Author_xml | – sequence: 1 givenname: Henju orcidid: 0000-0002-9153-5929 surname: Marjuki fullname: Marjuki, Henju organization: Meningitis and Vaccine Preventable Diseases Branch, Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA – sequence: 2 givenname: How-Yi surname: Chang fullname: Chang, How-Yi organization: IHRC Inc., Contractor to Meningitis and Vaccine Preventable Diseases Branch, Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA – sequence: 3 givenname: Nadav surname: Topaz fullname: Topaz, Nadav organization: CDC Foundation Field Employee assigned to the Meningitis and Vaccine Preventable Diseases Branch, Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA – sequence: 4 givenname: Melissa J. surname: Whaley fullname: Whaley, Melissa J. organization: Meningitis and Vaccine Preventable Diseases Branch, Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA – sequence: 5 givenname: Jeni surname: Vuong fullname: Vuong, Jeni organization: Meningitis and Vaccine Preventable Diseases Branch, Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA – sequence: 6 givenname: Alexander surname: Chen fullname: Chen, Alexander organization: Meningitis and Vaccine Preventable Diseases Branch, Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA – sequence: 7 givenname: Laurel T. surname: Jenkins fullname: Jenkins, Laurel T. organization: IHRC Inc., Contractor to Meningitis and Vaccine Preventable Diseases Branch, Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA – sequence: 8 givenname: Fang surname: Hu fullname: Hu, Fang organization: IHRC Inc., Contractor to Meningitis and Vaccine Preventable Diseases Branch, Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA – sequence: 9 givenname: Susanna surname: Schmink fullname: Schmink, Susanna organization: Meningitis and Vaccine Preventable Diseases Branch, Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA – sequence: 10 givenname: Adam C. orcidid: 0000-0001-7185-591X surname: Retchless fullname: Retchless, Adam C. organization: Meningitis and Vaccine Preventable Diseases Branch, Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA – sequence: 11 givenname: Jennifer D. surname: Thomas fullname: Thomas, Jennifer D. organization: Meningitis and Vaccine Preventable Diseases Branch, Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA – sequence: 12 givenname: Anna M. surname: Acosta fullname: Acosta, Anna M. organization: Meningitis and Vaccine Preventable Diseases Branch, Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA – sequence: 13 givenname: Lucy A. surname: McNamara fullname: McNamara, Lucy A. organization: Meningitis and Vaccine Preventable Diseases Branch, Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA – sequence: 14 givenname: Heidi M. orcidid: 0000-0002-9415-9340 surname: Soeters fullname: Soeters, Heidi M. organization: Meningitis and Vaccine Preventable Diseases Branch, Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA – sequence: 15 givenname: Sarah surname: Mbaeyi fullname: Mbaeyi, Sarah organization: Meningitis and Vaccine Preventable Diseases Branch, Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA – sequence: 16 givenname: Xin orcidid: 0000-0002-7157-0022 surname: Wang fullname: Wang, Xin organization: Meningitis and Vaccine Preventable Diseases Branch, Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/34006659$$D View this record in MEDLINE/PubMed |
| BookMark | eNp1kstu1DAUQCNUREvpki3yEiFS_MjD2SC1A5SRilhMy9Zy7JuMR4k9tZ1K3fEPfAT_xZfgeRS1CLyxdX187rV9n2cH1lnIspcEnxJC-bvx3LhTjHlZ5pQ8yY4oKXFel4QcPFgfZichrHAajBHO8LPskBUYV1XZHGU_L8BCNAp9MLfgg4l3yHXoC1hje6ecUnJAC_Cu925ao3P0TSplLKAzG00PNiA5OtujmfTeyB7QPLhBRgho5oYBVASNOu9GtIiTBhsTH9HV0gOga7vPaBJtLIrLbWxzYhE3ireIYlL--v4jTdWL7GknhwAn-_k4u_708Wr2Ob_8ejGfnV3msuA85rpSHWm7rtNtoytNJOWdxtAUijPFO4C6LbhuE1TTumJlwQpKGUBTy6KGsmPH2Xzn1U6uxNqbUfo74aQR24DzvZA-vdcAgmBNW1rSkvOqwCkhVS0jaSkbVmuFk-v9zrWe2hG0Svf3cngkfbxjzVL07lZwWtGmoEnwei_w7maCEMVogoJhkBbcFERKzhtck6JK6JsdKsNIxcpN3qZnSjWKTaOITaOIbaMIShL86mFhfyq6b4sEsB2gvAvBQyeUSX9i3KZOM_xXm_916l78b_43-MXdyg |
| CitedBy_id | crossref_primary_10_1016_j_jinf_2021_11_015 crossref_primary_10_1093_ofid_ofac162 crossref_primary_10_1186_s12866_023_03111_5 |
| Cites_doi | 10.1016/j.vaccine.2012.01.033 10.1073/pnas.1521142113 10.1016/j.vaccine.2017.11.040 10.1111/j.1574-6976.2006.00057.x 10.1099/00221287-148-6-1813 10.1093/nar/25.17.3389 10.1128/mSphere.00197-20 10.1371/journal.pone.0019361 10.1093/molbev/msj030 10.1016/j.vaccine.2012.07.065 10.1128/mSphere.00261-17 10.1016/j.vaccine.2013.01.021 10.1016/j.jinf.2019.09.001 10.1371/journal.pone.0065043 10.1128/IAI.70.2.702-707.2002 10.1080/00325481.2016.1203238 10.1128/JCM.01609-18 10.1093/cid/cix091 10.1016/j.vaccine.2012.12.022 10.1016/j.vaccine.2010.06.083 10.1186/1478-7954-11-17 10.1136/jcp.2004.016253 10.1128/jcm.42.1.320-328.2004 10.1080/21645515.2017.1264750 10.15585/mmwr.mm6619a6 10.1093/infdis/jix446 10.1089/cmb.2012.0021 10.1086/374740 10.3201/eid2503.181574 10.1097/INF.0b013e31827b0d24 10.1128/CVI.00825-13 10.1056/NEJMoa1900236 10.1586/erv.09.48 10.3201/eid1004.030247 10.1128/IAI.66.4.1334-1341.1998 10.1136/bmj.326.7385.365 10.1016/j.vaccine.2013.06.080 10.4161/hv.34293 10.1016/S1473-3099(12)70087-7 10.1186/1471-2105-11-595 10.1371/journal.pone.0107240 10.1038/srep12888 10.1016/j.tim.2006.01.007 10.14806/ej.17.1.200 10.1016/S1473-3099(10)70251-6 10.1080/21645515.2018.1454570 |
| ContentType | Journal Article |
| Copyright | Copyright © 2021 Marjuki et al. Copyright © 2021 Marjuki et al. 2021 Marjuki et al. |
| Copyright_xml | – notice: Copyright © 2021 Marjuki et al. – notice: Copyright © 2021 Marjuki et al. 2021 Marjuki et al. |
| DBID | AAYXX CITATION NPM 7X8 5PM DOA |
| DOI | 10.1128/mBio.00855-21 |
| DatabaseName | CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
| DatabaseTitleList | PubMed MEDLINE - Academic CrossRef |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Biology |
| EISSN | 2150-7511 |
| Editor | Rappuoli, Rino Pizza, Mariagrazia |
| Editor_xml | – sequence: 1 givenname: Mariagrazia surname: Pizza fullname: Pizza, Mariagrazia – sequence: 2 givenname: Rino surname: Rappuoli fullname: Rappuoli, Rino |
| ExternalDocumentID | oai_doaj_org_article_10d2b252588640db92cb31640a937dc0 PMC8262942 mBio00855-21 34006659 10_1128_mBio_00855_21 |
| Genre | Journal Article |
| GrantInformation_xml | – fundername: HHS | Centers for Disease Control and Prevention (CDC) grantid: MVPDB funderid: https://doi.org/10.13039/100000030 – fundername: ; grantid: MVPDB |
| GroupedDBID | --- 0R~ 53G 5VS AAFWJ AAGFI AAUOK AAYXX ADBBV AENEX AFPKN ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BCNDV BTFSW CITATION DIK E3Z EBS FRP GROUPED_DOAJ GX1 H13 HYE HZ~ KQ8 M48 O5R O5S O9- OK1 P2P PGMZT RHI RNS RPM RSF M~E NPM RHF - 0R ADACO BXI HZ 7X8 5PM |
| ID | FETCH-LOGICAL-a488t-d6cf1bfffdb9d6d1a28fd0e94c83c8fee7b48dbcf1727635434223ee97a47e5f3 |
| IEDL.DBID | M48 |
| ISSN | 2150-7511 |
| IngestDate | Wed Aug 27 01:22:46 EDT 2025 Thu Aug 21 18:17:31 EDT 2025 Fri Jul 11 05:06:52 EDT 2025 Tue Dec 28 13:59:06 EST 2021 Wed Feb 19 02:28:57 EST 2025 Thu Apr 24 23:08:58 EDT 2025 Tue Jul 01 01:52:47 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 3 |
| Keywords | FHbp genetic diversity NadA carriage whole-genome sequencing Neisseria meningitidis NhbA serogroup B meningococcal vaccines |
| Language | English |
| License | Copyright © 2021 Marjuki et al. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license. https://creativecommons.org/licenses/by/4.0 This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-a488t-d6cf1bfffdb9d6d1a28fd0e94c83c8fee7b48dbcf1727635434223ee97a47e5f3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| ORCID | 0000-0001-7185-591X 0000-0002-7157-0022 0000-0002-9153-5929 0000-0002-9415-9340 |
| OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1128/mBio.00855-21 |
| PMID | 34006659 |
| PQID | 2528907146 |
| PQPubID | 23479 |
| PageCount | 11 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_10d2b252588640db92cb31640a937dc0 pubmedcentral_primary_oai_pubmedcentral_nih_gov_8262942 proquest_miscellaneous_2528907146 asm2_journals_10_1128_mBio_00855_21 pubmed_primary_34006659 crossref_citationtrail_10_1128_mBio_00855_21 crossref_primary_10_1128_mBio_00855_21 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 20210518 |
| PublicationDateYYYYMMDD | 2021-05-18 |
| PublicationDate_xml | – month: 5 year: 2021 text: 20210518 day: 18 |
| PublicationDecade | 2020 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States – name: 1752 N St., N.W., Washington, DC |
| PublicationTitle | mBio |
| PublicationTitleAbbrev | mBio |
| PublicationTitleAlternate | mBio |
| PublicationYear | 2021 |
| Publisher | American Society for Microbiology |
| Publisher_xml | – name: American Society for Microbiology |
| References | e_1_3_2_26_2 e_1_3_2_49_2 Vesikari VSS (e_1_3_2_25_2) 2016 e_1_3_2_28_2 e_1_3_2_41_2 e_1_3_2_20_2 e_1_3_2_43_2 e_1_3_2_22_2 e_1_3_2_45_2 e_1_3_2_24_2 e_1_3_2_47_2 e_1_3_2_9_2 e_1_3_2_16_2 e_1_3_2_37_2 e_1_3_2_7_2 e_1_3_2_18_2 e_1_3_2_39_2 e_1_3_2_31_2 e_1_3_2_52_2 e_1_3_2_5_2 Cohn AC (e_1_3_2_10_2) 2013; 62 e_1_3_2_12_2 e_1_3_2_33_2 e_1_3_2_3_2 e_1_3_2_14_2 e_1_3_2_35_2 e_1_3_2_50_2 e_1_3_2_27_2 e_1_3_2_48_2 e_1_3_2_29_2 e_1_3_2_40_2 e_1_3_2_21_2 e_1_3_2_42_2 e_1_3_2_23_2 e_1_3_2_44_2 e_1_3_2_46_2 e_1_3_2_15_2 e_1_3_2_38_2 e_1_3_2_8_2 Thompson JD (e_1_3_2_51_2) 2002; 2 e_1_3_2_17_2 e_1_3_2_6_2 e_1_3_2_19_2 e_1_3_2_30_2 e_1_3_2_32_2 e_1_3_2_11_2 e_1_3_2_34_2 e_1_3_2_4_2 e_1_3_2_13_2 e_1_3_2_36_2 e_1_3_2_2_2 Christensen, H, May, M, Bowen, L, Hickman, M, Trotter, CL (B2) 2010; 10 Jiang, HQ, Hoiseth, SK, Harris, SL, McNeil, LK, Zhu, D, Tan, C, Scott, AA, Alexander, K, Mason, K, Miller, L, DaSilva, I, Mack, M, Zhao, XJ, Pride, MW, Andrew, L, Murphy, E, Hagen, M, French, R, Arora, A, Jones, TR, Jansen, KU, Zlotnick, GW, Anderson, AS (B28) 2010; 28 Donald, RG, Hawkins, JC, Hao, L, Liberator, P, Jones, TR, Harris, SL, Perez, JL, Eiden, JJ, Jansen, KU, Anderson, AS (B11) 2017; 13 Soeters, HM, Whaley, M, Alexander-Scott, N, Kanadanian, KV, MacNeil, JR, Martin, SW, McNamara, LA, Sicard, K, Vanner, C, Vuong, J, Wang, X, Bandy, U, Patel, M (B8) 2017; 64 Ramsay, ME, Andrews, NJ, Trotter, CL, Kaczmarski, EB, Miller, E (B32) 2003; 326 Zlotnick, GW, Jones, TR, Liberator, P, Hao, L, Harris, S, McNeil, LK, Zhu, D, Perez, J, Eiden, J, Jansen, KU, Anderson, AS (B29) 2015; 11 Chang, HY, Vuong, J, Hu, F, Liberator, P, Chen, A, Kretz, CB, Blain, A, Hao, L, Retchless, AC, Whaley, MJ, Anderson, AS, Wang, X (B37) 2019 Jafri, RZ, Ali, A, Messonnier, NE, Tevi-Benissan, C, Durrheim, D, Eskola, J, Fermon, F, Klugman, KP, Ramsay, M, Sow, S, Zhujun, S, Bhutta, ZA, Abramson, J (B1) 2013; 11 Richmond, PC, Nissen, MD, Marshall, HS, Lambert, SB, Roberton, D, Gruber, WC, Jones, TR, Arora, A (B23) 2012; 30 Joseph, SJ, Topaz, N, Chang, HY, Whaley, MJ, Vuong, JT, Chen, A, Hu, F, Schmink, SE, Jenkins, LT, Rodriguez-Rivera, LD, Thomas, JD, Acosta, AM, McNamara, L, Soeters, HM, Mbaeyi, S, Wang, X (B36) 2020; 5 Jolley, KA, Maiden, MC (B46) 2010; 11 Serruto, D, Bottomley, MJ, Ram, S, Giuliani, MM, Rappuoli, R (B13) 2012; 30 Katial, RK, Brandt, BL, Moran, EE, Marks, S, Agnello, V, Zollinger, WD (B35) 2002; 70 Marjuki, H, Topaz, N, Rodriguez-Rivera, LD, Ramos, E, Potts, CC, Chen, A, Retchless, AC, Doho, GH, Wang, X (B44) 2018; 57 B4 Thompson, JD, Gibson, TJ, Higgins, DG (B50) 2002; Chapter 2 Marshall, HS, McMillan, M, Koehler, AP, Lawrence, A, Sullivan, TR, MacLennan, JM, Maiden, MCJ, Ladhani, SN, Ramsay, ME, Trotter, C, Borrow, R, Finn, A, Kahler, CM, Whelan, J, Vadivelu, K, Richmond, P (B17) 2020; 382 Trotter, CL, Maiden, MC (B30) 2009; 8 Altschul, SF, Madden, TL, Schaffer, AA, Zhang, J, Zhang, Z, Miller, W, Lipman, DJ (B45) 1997; 25 B41 Balmer, P, Burman, C, Serra, L, York, LJ (B3) 2018; 14 Nissen, MD, Marshall, HS, Richmond, PC, Jiang, Q, Harris, SL, Jones, TR, Jansen, KU, Perez, JL (B21) 2013; 32 McNamara, LA, Thomas, JD, MacNeil, J, Chang, HY, Day, M, Fisher, E, Martin, S, Poissant, T, Schmink, SE, Steward-Clark, E, Jenkins, LT, Wang, X, Acosta, A (B7) 2017; 216 Marshall, HS, Richmond, PC, Nissen, MD, Wouters, A, Baber, J, Jiang, Q, Anderson, AS, Jones, TR, Harris, SL, Jansen, KU, Perez, JL (B20) 2013; 31 Claus, H, Maiden, MC, Maag, R, Frosch, M, Vogel, U (B5) 2002; 148 Patton, ME, Stephens, D, Moore, K, MacNeil, JR (B14) 2017; 66 Mothershed, EA, Sacchi, CT, Whitney, AM, Barnett, GA, Ajello, GW, Schmink, S, Mayer, LW, Phelan, M, Taylor, TH, Bernhardt, SA, Rosenstein, NE, Popovic, T (B40) 2004; 42 Hong, E, Giuliani, MM, Deghmane, AE, Comanducci, M, Brunelli, B, Dull, P, Pizza, M, Taha, MK (B15) 2013; 31 Breakwell, L, Whaley, M, Khan, UI, Bandy, U, Alexander-Scott, N, Dupont, L, Vanner, C, Chang, HY, Vuong, JT, Martin, S, MacNeil, JR, Wang, X, Meyer, SA (B19) 2018; 36 Soeters, HM, McNamara, LA, Blain, AE, Whaley, M, MacNeil, JR, Hariri, S, Mbaeyi, SA (B18) 2019; 25 Huson, DH, Bryant, D (B51) 2006; 23 Delbos, V, Lemee, L, Benichou, J, Berthelot, G, Deghmane, AE, Leroy, JP, Houivet, E, Hong, E, Taha, MK, Caron, F (B16) 2013; 31 Zhang, Q, Finn, A (B31) 2004; 57 Vesikari, VSS, Absalon, J, Eiden, JJ, Jansen, KU, Beeslaar, J, York, LJ, Jones, TR, Maansson, R, Harris, SL (B24) 2016 Dolan-Livengood, JM, Miller, YK, Martin, LE, Urwin, R, Stephens, DS (B6) 2003; 187 Heyderman, RS, Davenport, V, Williams, NA (B33) 2006; 14 Bankevich, A, Nurk, S, Antipov, D, Gurevich, AA, Dvorkin, M, Kulikov, AS, Lesin, VM, Nikolenko, SI, Pham, S, Prjibelski, AD, Pyshkin, AV, Sirotkin, AV, Vyahhi, N, Tesler, G, Alekseyev, MA, Pevzner, PA (B43) 2012; 19 Russell, JE, Jolley, KA, Feavers, IM, Maiden, MC, Suker, J (B49) 2004; 10 Jolley, KA, Brehony, C, Maiden, MC (B47) 2007; 31 Cohn, AC, MacNeil, JR, Clark, TA, Ortega-Sanchez, IR, Briere, EZ, Meissner, HC, Baker, CJ, Messonnier, NE (B9) 2013; 62 Lemee, L, Hong, E, Etienne, M, Deghmane, AE, Delbos, V, Terrade, A, Berthelot, G, Caron, F, Taha, MK (B25) 2014; 9 Gandhi, A, Balmer, P, York, LJ (B10) 2016; 128 Dolan Thomas, J, Hatcher, CP, Satterfield, DA, Theodore, MJ, Bach, MC, Linscott, KB, Zhao, X, Wang, X, Mair, R, Schmink, S, Arnold, KE, Stephens, DS, Harrison, LH, Hollick, RA, Andrade, AL, Lamaro-Cardoso, J, de Lemos, AP, Gritzfeld, J, Gordon, S, Soysal, A, Bakir, M, Sharma, D, Jain, S, Satola, SW, Messonnier, NE, Mayer, LW (B39) 2011; 6 Bambini, S, De Chiara, M, Muzzi, A, Mora, M, Lucidarme, J, Brehony, C, Borrow, R, Masignani, V, Comanducci, M, Maiden, MC, Rappuoli, R, Pizza, M, Jolley, KA (B48) 2014; 21 Haneberg, B, Dalseg, R, Wedege, E, Hoiby, EA, Haugen, IL, Oftung, F, Andersen, SR, Naess, LM, Aase, A, Michaelsen, TE, Holst, J (B34) 1998; 66 Rajam, G, Stella, M, Kim, E, Paulos, S, Boccadifuoco, G, Serino, L, Carlone, G, Medini, D (B38) 2017; 2 Biagini, M, Spinsanti, M, De Angelis, G, Tomei, S, Ferlenghi, I, Scarselli, M, Rigat, F, Messuti, N, Biolchi, A, Muzzi, A, Anderloni, G, Brunelli, B, Cartocci, E, Buricchi, F, Tani, C, Stella, M, Moschioni, M, Del Tordello, E, Colaprico, A, Savino, S, Giuliani, MM, Delany, I, Pizza, M, Costantino, P, Norais, N, Rappuoli, R, Masignani, V (B27) 2016; 113 Bambini, S, Piet, J, Muzzi, A, Keijzers, W, Comandi, S, De, TL, Pizza, M, Rappuoli, R, van de Beek, D, van der Ende, A, Comanducci, M (B12) 2013; 8 Xu, Y, Liu, B, Grondahl-Yli-Hannuksila, K, Tan, Y, Feng, L, Kallonen, T, Wang, L, Peng, D, He, Q, Wang, L, Zhang, S (B26) 2015; 5 Richmond, PC, Marshall, HS, Nissen, MD, Jiang, Q, Jansen, KU, Garces-Sanchez, M, Martinon-Torres, F, Beeslaar, J, Szenborn, L, Wysocki, J, Eiden, J, Harris, SL, Jones, TR, Perez, JL (B22) 2012; 12 Martin, M (B42) 2011 |
| References_xml | – ident: e_1_3_2_14_2 doi: 10.1016/j.vaccine.2012.01.033 – ident: e_1_3_2_28_2 doi: 10.1073/pnas.1521142113 – ident: e_1_3_2_20_2 doi: 10.1016/j.vaccine.2017.11.040 – ident: e_1_3_2_48_2 doi: 10.1111/j.1574-6976.2006.00057.x – ident: e_1_3_2_6_2 doi: 10.1099/00221287-148-6-1813 – ident: e_1_3_2_46_2 doi: 10.1093/nar/25.17.3389 – ident: e_1_3_2_37_2 doi: 10.1128/mSphere.00197-20 – ident: e_1_3_2_40_2 doi: 10.1371/journal.pone.0019361 – ident: e_1_3_2_52_2 doi: 10.1093/molbev/msj030 – ident: e_1_3_2_24_2 doi: 10.1016/j.vaccine.2012.07.065 – ident: e_1_3_2_39_2 doi: 10.1128/mSphere.00261-17 – ident: e_1_3_2_21_2 doi: 10.1016/j.vaccine.2013.01.021 – ident: e_1_3_2_38_2 doi: 10.1016/j.jinf.2019.09.001 – ident: e_1_3_2_13_2 doi: 10.1371/journal.pone.0065043 – ident: e_1_3_2_42_2 – ident: e_1_3_2_36_2 doi: 10.1128/IAI.70.2.702-707.2002 – ident: e_1_3_2_11_2 doi: 10.1080/00325481.2016.1203238 – ident: e_1_3_2_45_2 doi: 10.1128/JCM.01609-18 – ident: e_1_3_2_5_2 – ident: e_1_3_2_9_2 doi: 10.1093/cid/cix091 – ident: e_1_3_2_16_2 doi: 10.1016/j.vaccine.2012.12.022 – ident: e_1_3_2_29_2 doi: 10.1016/j.vaccine.2010.06.083 – ident: e_1_3_2_2_2 doi: 10.1186/1478-7954-11-17 – ident: e_1_3_2_32_2 doi: 10.1136/jcp.2004.016253 – ident: e_1_3_2_41_2 doi: 10.1128/jcm.42.1.320-328.2004 – ident: e_1_3_2_12_2 doi: 10.1080/21645515.2017.1264750 – ident: e_1_3_2_15_2 doi: 10.15585/mmwr.mm6619a6 – ident: e_1_3_2_8_2 doi: 10.1093/infdis/jix446 – ident: e_1_3_2_44_2 doi: 10.1089/cmb.2012.0021 – ident: e_1_3_2_7_2 doi: 10.1086/374740 – ident: e_1_3_2_19_2 doi: 10.3201/eid2503.181574 – ident: e_1_3_2_22_2 doi: 10.1097/INF.0b013e31827b0d24 – ident: e_1_3_2_49_2 doi: 10.1128/CVI.00825-13 – ident: e_1_3_2_18_2 doi: 10.1056/NEJMoa1900236 – ident: e_1_3_2_31_2 doi: 10.1586/erv.09.48 – ident: e_1_3_2_50_2 doi: 10.3201/eid1004.030247 – ident: e_1_3_2_35_2 doi: 10.1128/IAI.66.4.1334-1341.1998 – ident: e_1_3_2_33_2 doi: 10.1136/bmj.326.7385.365 – ident: e_1_3_2_17_2 doi: 10.1016/j.vaccine.2013.06.080 – volume: 2 start-page: Unit 2.3 year: 2002 ident: e_1_3_2_51_2 article-title: Multiple sequence alignment using ClustalW and ClustalX publication-title: Curr Protoc Bioinformatics – ident: e_1_3_2_30_2 doi: 10.4161/hv.34293 – ident: e_1_3_2_23_2 doi: 10.1016/S1473-3099(12)70087-7 – ident: e_1_3_2_47_2 doi: 10.1186/1471-2105-11-595 – ident: e_1_3_2_26_2 doi: 10.1371/journal.pone.0107240 – volume: 62 start-page: 1 year: 2013 ident: e_1_3_2_10_2 article-title: Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP) publication-title: MMWR Recomm Rep – ident: e_1_3_2_27_2 doi: 10.1038/srep12888 – ident: e_1_3_2_34_2 doi: 10.1016/j.tim.2006.01.007 – ident: e_1_3_2_43_2 doi: 10.14806/ej.17.1.200 – ident: e_1_3_2_3_2 doi: 10.1016/S1473-3099(10)70251-6 – volume-title: Phase 3 trial of immunogenicity of bivalent rLP2086, a meningococcal serogroup B vaccine, in adolescents: bactericidal activity against a panel of antigenically diverse strains year: 2016 ident: e_1_3_2_25_2 – ident: e_1_3_2_4_2 doi: 10.1080/21645515.2018.1454570 – volume: 57 start-page: 1015 year: 2004 end-page: 1021 ident: B31 article-title: Mucosal immunology of vaccines against pathogenic nasopharyngeal bacteria publication-title: J Clin Pathol doi: 10.1136/jcp.2004.016253 – volume: 62 start-page: 1 year: 2013 end-page: 28 ident: B9 article-title: Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP) publication-title: MMWR Recomm Rep – volume: 28 start-page: 6086 year: 2010 end-page: 6093 ident: B28 article-title: Broad vaccine coverage predicted for a bivalent recombinant factor H binding protein based vaccine to prevent serogroup B meningococcal disease publication-title: Vaccine doi: 10.1016/j.vaccine.2010.06.083 – volume: 5 start-page: 12888 year: 2015 ident: B26 article-title: Whole-genome sequencing reveals the effect of vaccination on the evolution of Bordetella pertussis publication-title: Sci Rep doi: 10.1038/srep12888 – volume: 30 start-page: B87 year: 2012 end-page: B97 ident: B13 article-title: The new multicomponent vaccine against meningococcal serogroup B, 4CMenB: immunological, functional and structural characterization of the antigens publication-title: Vaccine doi: 10.1016/j.vaccine.2012.01.033 – volume: 31 start-page: 1569 year: 2013 end-page: 1575 ident: B20 article-title: A phase 2 open-label safety and immunogenicity study of a meningococcal B bivalent rLP2086 vaccine in healthy adults publication-title: Vaccine doi: 10.1016/j.vaccine.2013.01.021 – ident: B4 article-title: Anonymous . 2018 . Enhanced meningococcal disease surveillance report . https://wwwcdcgov/meningococcal/downloads/NCIRD-EMS-Report-2018pdf . – volume: 8 start-page: 851 year: 2009 end-page: 861 ident: B30 article-title: Meningococcal vaccines and herd immunity: lessons learned from serogroup C conjugate vaccination programs publication-title: Expert Rev Vaccines doi: 10.1586/erv.09.48 – volume: 31 start-page: 89 year: 2007 end-page: 96 ident: B47 article-title: Molecular typing of meningococci: recommendations for target choice and nomenclature publication-title: FEMS Microbiol Rev doi: 10.1111/j.1574-6976.2006.00057.x – volume: 13 start-page: 255 year: 2017 end-page: 265 ident: B11 article-title: Meningococcal serogroup B vaccines: estimating breadth of coverage publication-title: Hum Vaccin Immunother doi: 10.1080/21645515.2017.1264750 – volume: 2 year: 2017 ident: B38 article-title: Meningococcal antigen typing system (MATS)-based Neisseria meningitidis serogroup B coverage prediction for the MenB-4C vaccine in the United States publication-title: mSphere doi: 10.1128/mSphere.00261-17 – volume: 21 start-page: 966 year: 2014 end-page: 971 ident: B48 article-title: Neisseria adhesin A variation and revised nomenclature scheme publication-title: Clin Vaccine Immunol doi: 10.1128/CVI.00825-13 – year: 2011 ident: B42 article-title: Cutadapt removes adapter sequences from high-throughput sequencing reads publication-title: EMBnet J doi: 10.14806/ej.17.1.200 – volume: 23 start-page: 254 year: 2006 end-page: 267 ident: B51 article-title: Application of phylogenetic networks in evolutionary studies publication-title: Mol Biol Evol doi: 10.1093/molbev/msj030 – volume: 11 start-page: 595 year: 2010 ident: B46 article-title: BIGSdb: scalable analysis of bacterial genome variation at the population level publication-title: BMC Bioinformatics doi: 10.1186/1471-2105-11-595 – volume: 187 start-page: 1616 year: 2003 end-page: 1628 ident: B6 article-title: Genetic basis for nongroupable Neisseria meningitidis publication-title: J Infect Dis doi: 10.1086/374740 – volume: 8 year: 2013 ident: B12 article-title: An analysis of the sequence variability of meningococcal fHbp, NadA and NHBA over a 50-year period in the Netherlands publication-title: PLoS One doi: 10.1371/journal.pone.0065043 – volume: 14 start-page: 1118 year: 2018 end-page: 1130 ident: B3 article-title: Impact of meningococcal vaccination on carriage and disease transmission: a review of the literature publication-title: Hum Vaccin Immunother doi: 10.1080/21645515.2018.1454570 – volume: 12 start-page: 597 year: 2012 end-page: 607 ident: B22 article-title: Safety, immunogenicity, and tolerability of meningococcal serogroup B bivalent recombinant lipoprotein 2086 vaccine in healthy adolescents: a randomised, single-blind, placebo-controlled, phase 2 trial publication-title: Lancet Infect Dis doi: 10.1016/S1473-3099(12)70087-7 – volume: 128 start-page: 548 year: 2016 end-page: 556 ident: B10 article-title: Characteristics of a new meningococcal serogroup B vaccine, bivalent rLP2086 (MenB-FHbp; Trumenba) publication-title: Postgrad Med doi: 10.1080/00325481.2016.1203238 – volume: 57 year: 2018 ident: B44 article-title: Whole genome sequencing to characterize capsule locus and predict serogroup of invasive meningococcal isolates publication-title: J Clin Microbiol doi: 10.1128/JCM.01609-18 – volume: 113 start-page: 2714 year: 2016 end-page: 2719 ident: B27 article-title: Expression of factor H binding protein in meningococcal strains can vary at least 15-fold and is genetically determined publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.1521142113 – year: 2019 ident: B37 article-title: Distribution of Neisseria meningitidis serogroup B (NmB) vaccine antigens in meningococcal disease causing isolates in the United States during 2009–2014, prior to NmB vaccine licensure publication-title: J Infect doi: 10.1016/j.jinf.2019.09.001 – volume: 31 start-page: 1113 year: 2013 end-page: 1116 ident: B15 article-title: Could the multicomponent meningococcal serogroup B vaccine (4CMenB) control Neisseria meningitidis capsular group X outbreaks in Africa? publication-title: Vaccine doi: 10.1016/j.vaccine.2012.12.022 – volume: 42 start-page: 320 year: 2004 end-page: 328 ident: B40 article-title: Use of real-time PCR to resolve slide agglutination discrepancies in serogroup identification of Neisseria meningitidis publication-title: J Clin Microbiol doi: 10.1128/jcm.42.1.320-328.2004 – volume: 148 start-page: 1813 year: 2002 end-page: 1819 ident: B5 article-title: Many carried meningococci lack the genes required for capsule synthesis and transport publication-title: Microbiology doi: 10.1099/00221287-148-6-1813 – volume: 31 start-page: 4416 year: 2013 end-page: 4420 ident: B16 article-title: Impact of MenBvac, an outer membrane vesicle (OMV) vaccine, on the meningococcal carriage publication-title: Vaccine doi: 10.1016/j.vaccine.2013.06.080 – volume: 11 start-page: 5 year: 2015 end-page: 13 ident: B29 article-title: The discovery and development of a novel vaccine to protect against Neisseria meningitidis serogroup B disease publication-title: Hum Vaccin Immunother doi: 10.4161/hv.34293 – volume: 64 start-page: 1115 year: 2017 end-page: 1122 ident: B8 article-title: Meningococcal carriage evaluation in response to a serogroup B meningococcal disease outbreak and mass vaccination campaign at a college-Rhode Island, 2015–2016 publication-title: Clin Infect Dis doi: 10.1093/cid/cix091 – volume: 10 start-page: 853 year: 2010 end-page: 861 ident: B2 article-title: Meningococcal carriage by age: a systematic review and meta-analysis publication-title: Lancet Infect Dis doi: 10.1016/S1473-3099(10)70251-6 – volume: 32 start-page: 364 year: 2013 end-page: 371 ident: B21 article-title: A randomized, controlled, phase 1/2 trial of a Neisseria meningitidis serogroup B bivalent rLP2086 vaccine in healthy children and adolescents publication-title: Pediatr Infect Dis J doi: 10.1097/INF.0b013e31827b0d24 – volume: 19 start-page: 455 year: 2012 end-page: 477 ident: B43 article-title: SPAdes: a new genome assembly algorithm and its applications to single-cell sequencing publication-title: J Comp Biol doi: 10.1089/cmb.2012.0021 – volume: 30 start-page: 6163 year: 2012 end-page: 6174 ident: B23 article-title: A bivalent Neisseria meningitidis recombinant lipidated factor H binding protein vaccine in young adults: results of a randomised, controlled, dose-escalation phase 1 trial publication-title: Vaccine doi: 10.1016/j.vaccine.2012.07.065 – volume: 5 year: 2020 ident: B36 article-title: Insights on population structure and within-host genetic changes among meningococcal carriage isolates from U.S. universities publication-title: mSphere doi: 10.1128/mSphere.00197-20 – volume: 11 start-page: 17 year: 2013 ident: B1 article-title: Global epidemiology of invasive meningococcal disease publication-title: Popul Health Metr doi: 10.1186/1478-7954-11-17 – volume: 25 start-page: 3389 year: 1997 end-page: 3402 ident: B45 article-title: Gapped BLAST and PSI-BLAST: a new generation of protein database search programs publication-title: Nucleic Acids Res doi: 10.1093/nar/25.17.3389 – year: 2016 ident: B24 publication-title: Phase 3 trial of immunogenicity of bivalent rLP2086, a meningococcal serogroup B vaccine, in adolescents: bactericidal activity against a panel of antigenically diverse strains ;European Society Pediatric Infectious Diseases ;Brighton, UK – volume: 326 start-page: 365 year: 2003 end-page: 366 ident: B32 article-title: Herd immunity from meningococcal serogroup C conjugate vaccination in England: database analysis publication-title: BMJ doi: 10.1136/bmj.326.7385.365 – volume: 382 start-page: 318 year: 2020 end-page: 327 ident: B17 article-title: Meningococcal B vaccine and meningococcal carriage in adolescents in Australia publication-title: N Engl J Med doi: 10.1056/NEJMoa1900236 – volume: 25 start-page: 434 year: 2019 end-page: 440 ident: B18 article-title: University-based outbreaks of meningococcal disease caused by serogroup B, United States, 2013–2018 publication-title: Emerg Infect Dis doi: 10.3201/eid2503.181574 – ident: B41 article-title: WHO . 2011 . Laboratory methods for the diagnosis of meningitis caused by Neisseria meningitidis, Streptococcus pneumoniae, and Haemophilus influenzae . http://www.cdc.gov/meningitis/lab-manual/full-manual.pdf . – volume: 36 start-page: 29 year: 2018 end-page: 35 ident: B19 article-title: Meningococcal carriage among a university student population–United States, 2015 publication-title: Vaccine doi: 10.1016/j.vaccine.2017.11.040 – volume: 14 start-page: 120 year: 2006 end-page: 124 ident: B33 article-title: Mucosal immunity and optimizing protection with meningococcal serogroup B vaccines publication-title: Trends Microbiol doi: 10.1016/j.tim.2006.01.007 – volume: 10 start-page: 674 year: 2004 end-page: 678 ident: B49 article-title: PorA variable regions of Neisseria meningitidis publication-title: Emerg Infect Dis doi: 10.3201/eid1004.030247 – volume: Chapter 2 start-page: Unit 2.3 year: 2002 ident: B50 article-title: Multiple sequence alignment using ClustalW and ClustalX publication-title: Curr Protoc Bioinformatics – volume: 66 start-page: 509 year: 2017 end-page: 513 ident: B14 article-title: Updated recommendations for use of MenB-FHbp serogroup B meningococcal vaccine. Advisory Committee on Immunization Practices, 2016 publication-title: MMWR Morb Mortal Wkly Rep doi: 10.15585/mmwr.mm6619a6 – volume: 70 start-page: 702 year: 2002 end-page: 707 ident: B35 article-title: Immunogenicity and safety testing of a group B intranasal meningococcal native outer membrane vesicle vaccine publication-title: Infect Immun doi: 10.1128/IAI.70.2.702-707.2002 – volume: 216 start-page: 1130 year: 2017 end-page: 1140 ident: B7 article-title: Meningococcal carriage following a vaccination campaign with MenB-4C and MenB-FHbp in response to a university serogroup B meningococcal disease outbreak-Oregon, 2015–2016 publication-title: J Infect Dis doi: 10.1093/infdis/jix446 – volume: 6 year: 2011 ident: B39 article-title: sodC-based real-time PCR for detection of Neisseria meningitidis publication-title: PLoS One doi: 10.1371/journal.pone.0019361 – volume: 9 year: 2014 ident: B25 article-title: Genetic diversity and levels of expression of factor H binding protein among carriage isolates of Neisseria meningitidis publication-title: PLoS One doi: 10.1371/journal.pone.0107240 – volume: 66 start-page: 1334 year: 1998 end-page: 1341 ident: B34 article-title: Intranasal administration of a meningococcal outer membrane vesicle vaccine induces persistent local mucosal antibodies and serum antibodies with strong bactericidal activity in humans publication-title: Infect Immun doi: 10.1128/IAI.66.4.1334-1341.1998 |
| SSID | ssj0000331830 |
| Score | 2.2965 |
| Snippet | The impact of serogroup B meningococcal (MenB) vaccines on carriage is not completely understood. Using whole-genome sequencing data, we assessed the diversity... Carriage evaluations were conducted during 2015 to 2016 at two U.S. universities in conjunction with the response to disease outbreaks caused by serogroup B... Carriage evaluations were conducted during 2015 to 2016 at two U.S. universities in conjunction with the response to disease outbreaks caused by Neisseria... Carriage evaluations were conducted during 2015 to 2016 at two U.S. universities in conjunction with the response to disease outbreaks caused by Neisseria... |
| SourceID | doaj pubmedcentral proquest asm2 pubmed crossref |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
| SubjectTerms | Research Article |
| SummonAdditionalLinks | – databaseName: American Society for Microbiology Open Access dbid: AAUOK link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3NbtQwELaqrZC4IP4JBTQIxKkpieM49nG3UBVQ4UAX9Rb5t6xEk6qbHrjxDjwE78WTMHZ-xFZU4rTSZrwbeWbsb-yZbwh5qQptueQy5YVSaWivnWr0uVSJ3Bgqc-10qB0--sgPl-z9SXmyRehYCzPM4HpPrc_iRf7k2VS8Plus2r2YWZWG2vHtkkqWzcj2fL789GE6WcmKYKfZSKh5dRyuvfjbdGMfinT9_8KYV1Ml_9p7Dm6TWwNohHmv5TtkyzV3yY2-jeT3e-RX4I7GR_BmTLKA1sORC0ceLS54qAbANaGNFRywgC_KhOt0mDdd4OJcQ-w4BPvqAq3x1ME7tMcAQSGeKhjEpBCqUOBzz4OJ8h0cow04mNI6MN6GVQOIJqFHsdCj2F3Arb_8_eMnfvD7ZHnw9nj_MB0aMKQK_bpLLTc-1957q6XlNldUeJs5yYwojPDOVZoJq1EIURAiF1YwRBvOyUqxypW-eEBmTdu4RwRKyowtNM9spljpqfKSa1lhKM99JpVOyIuglXrUfx2DEyrqoLs66q6meUJ2R6XVZuAwD600vl0n_moSP-_JO64TXAQLmIQC53b8Ai2wHlwYR1qqaUlLITjLcEqo0QVGm5lCiGdNlpDno_3U6KPh4kU1rr1c1zhIyFApxhPysLen6a8KFm-_ZEKqDUvbeJfNJ83qa-QBx8gQHYA-_q-p2yE3aUjHCcSz4gmZdReX7iniqU4_GxzoD8gkH5Y priority: 102 providerName: American Society for Microbiology – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NbtQwELbQSkhcEP8EChoE4tRA4jiOfewWqoJULrSot8i_sBJNUDc99MY78BC8F0_CjJNd7SIqLpwibWYVK_ON_U08_oaxF6ayXmqpc1kZk1N77dxizOVGlc5xXdpg6ezw0Qd5eCLen9anG62-qCZslAceXxxGteeW17xWSorCW82drZDjFwYXVu9Sto5r3kYylebgirBarEQ1uXp9Nl_0r1JVVk66oDOzPONba1GS7P8bz_yzXHJj_Tm4xW5OxBH2xgHfZtdCd4ddH1tJXt5lP0k_Gm_Bm1WhBfQRjgJ99uhx0kNXAM4LfTrFAXP4ZBxtqcNeN5Ae5xJS1yHYN-eIyM8B3iEmiYZC-rLgkJcCnUSBj6MWJtoPcIw4CLAu7cCcGxYdIKOEkcnCyGR3AZf_-tf3H3iR99jJwdvj_cN8asKQG4ztIffSxdLGGPHVe-lLw1X0RdDCqcqpGEJjhfIWjZAJIXsRlUDGEYJujGhCHav7bNb1XXjIoObC-crKwhdG1JGbqKXVDabzMhba2Iw9J6-0UxQt25SgcNWS79rku5aXGdtdOa11k445tdP4epX5y7X5t1HA4yrDOSFgbUS62-kHRGM7obH9Fxoz9myFnxbjlDZfTBf6i2WLf1KaTovJjD0Y8bR-VCXSDpjOWLOFtK2xbN_pFl-SFjhmh1wL_uh_DP4xu8GpYoe0adUOmw3nF-EJUq7BPk3R9RtosyrI priority: 102 providerName: Directory of Open Access Journals |
| Title | Genetic Diversity of Meningococcal Serogroup B Vaccine Antigens among Carriage Isolates Collected from Students at Three Universities in the United States, 2015–2016 |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/34006659 https://journals.asm.org/doi/10.1128/mBio.00855-21 https://www.proquest.com/docview/2528907146 https://pubmed.ncbi.nlm.nih.gov/PMC8262942 https://doaj.org/article/10d2b252588640db92cb31640a937dc0 |
| Volume | 12 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV1LbxMxELZQK1AviHfDIxoE4tQtu16v1z4glBRKAQUONKi3lZ8lUrsLSSrRH8T_ZOzdDaRqLjlkx8nKM2N_Y898Q8hLlWvLJZcJz5VKQnvtRKPPJUpkxlCZaadD7fDkCz-ask8nxck_SqFuAhfXhnahn9R0frb_-9flW3T4N20BjHh9Pp41-zHhKgkl5du4KZXBRycd0o-Lch6MN-1ZNq-O2iG3chavIUJKl1qc07V9KtL5X4dBr6ZS_rc3Hd4htztQCaPWCu6SG66-R262bSYv75M_gVsaH8G7PgkDGg8TF45EGlwQUU2Aa0YTKzxgDN-VCdftMKqXgatzAbEjERyoOVrrqYOPaK8BokI8dTCIWSFUqcC3licT5ZdwjDbiYJX2gfE4zGpAtAktyoUW5e4BQgOcGoSED8j08P3xwVHStWdIFHr9MrHc-Ex7762WlttMUeFt6iQzIjfCO1dqJqxGIcRIiGtYzhCLOCdLxUpX-Pwh2aqb2u0SKCgzNtc8talihafKS65liYE-96lUekBeBJ1UvXlUMXShogpKrKISK5oNyF6vssp0DOeh0cbZJvFXK_GfLbXHJsFx0P9KKDByxy-a-WnVOTiOtFTTghZCcJbilFCjc4xFU4UA0Jp0QJ731lOhB4drGVW75mJR4SAhQx0ZH5BHrTWt_qo3ygEp1-xs7V3Wn9SzH5ElHONGKhl9vPE3n5AdGhJ0AhWteEq2lvML9wwR1lIPyfZoNP36eRhPKPDzw0k2jP70Fz48J5o |
| linkProvider | Scholars Portal |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lb9NAEF5VrRBcEG_CcxCIU12c9Xqze0wKVUubciBBvVn7hKDWRk164MZ_4Efwv_glzKydiFRU4mTJnpUtzze73-68GHtlCuulljqThTEZtdfOLNpcZlTfOa77NljKHR4fy_2peH9SnmwwucyF-Up9eU_nO2Z-lvz4ZNh0EN31I1RvzkazZidFV2WUP75FfkNE9tZwOP1wuDpdyQvCar4sqnl5HM6_-AK-thalkv3_4pmXwyX_Wn_2brGbHXGEYavp22wj1HfYtbaV5Pe77BfVj8ZH8HYZaAFNhHGgY48GJz1UBeC80KQsDhjBJ-PIpQ7DekH1OOeQug7BrjlHRH4OcICYJBoK6WTBIS8FykSBj20tTJRfwARxEGAV2oF7bpjVgIwSWiYLLZPdBlz-y98_fuJF3mPTvXeT3f2sa8KQGbTtReali30bY_RWe-n7hqvo86CFU4VTMYSBFcpbFEImhOxFFAIZRwh6YMQglLG4zzbrpg4PGZRcOF9YmfvciDJyE7W0eoDbeRlzbWyPvSStVJ0Vzau0QeGqIt1VSXcV7_fY9lJplevqmFM7jdOrxF-vxL-1BTyuEhwRAlZCVHc73UAYVp0Z40jPLS95qZQUOf4S7myBO87cIM3zLu-xF0v8VGin5HwxdWgu5hUOUpqyxWSPPWjxtHpVIZIHTPfYYA1pa9-y_qSefUm1wHF3yLXgj_7r1z1n1_cn46Pq6OD48DG7wSk8hwrRqidsc3F-EZ4iv1rYZ50x_QHWFCP5 |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1LbxMxELaqViAuiDfhOQjEqVs2Xq9jH5OWqKW0INGi3lZ-QiS6WzXpgRv_gR_B_-KXMOPdjUhFJU6RsuNk5fnG_saeB2OvTGG91FJnsjAmo_bamUWby4waOsf10AZLucMHh3L3WLw7KU_WmOxzYboZnG-Z-Wm6yCfLPvOx60eo3pxOZs1Wiq7KKH98gy6qEN8b4_Hxh_3l6UpeEFbzvqjm5XG4_uLv85W9KJXs_xfPvBwu-df-M73FbnbEEcatpm-ztVDfYdfaVpLf77JfVD8aH8FOH2gBTYSDQMceDS56qArAdaFJWRwwgc_G0ZU6jOsF1eOcQ-o6BNvmHBH5JcAeYpJoKKSTBYe8FCgTBT61tTBRfgFHiIMAy9AO9LlhVgMySmiZLLRMdhNw-y9___iJH_IeO56-PdrezbomDJlB215kXro4tDFGb7WXfmi4ij4PWjhVOBVDGFmhvEUhZELIXkQhkHGEoEdGjEIZi_tsvW7q8JBByYXzhZW5z40oIzdRS6tH6M7LmGtjB-wlaaXqMVAlB4WrinRXJd1VfDhgm73SKtfVMad2Gt-uEn-9FD9rC3hcJTghBCyFqO52-gJRWHVmjCM9t7zkpVJS5Dgl3NkCPc7cIM3zLh-wFz1-KrRTunwxdWgu5hUOUpqyxeSAPWjxtPyrQqQbMD1goxWkrbzL6pN69jXVAkfvkGvBH_3X1D1n1z_uTKv3e4f7j9kNTtE5VIdWPWHri_OL8BTp1cI-62zpD5MXI5U |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Genetic+Diversity+of+Meningococcal+Serogroup+B+Vaccine+Antigens+among+Carriage+Isolates+Collected+from+Students+at+Three+Universities+in+the+United+States%2C+2015-2016&rft.jtitle=mBio&rft.au=Marjuki%2C+Henju&rft.au=Chang%2C+How-Yi&rft.au=Topaz%2C+Nadav&rft.au=Whaley%2C+Melissa+J&rft.date=2021-05-18&rft.eissn=2150-7511&rft.volume=12&rft.issue=3&rft_id=info:doi/10.1128%2FmBio.00855-21&rft_id=info%3Apmid%2F34006659&rft.externalDocID=34006659 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2150-7511&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2150-7511&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2150-7511&client=summon |